-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Targeting Immune/Inflammatory-Related Pathways in Myeloid Malignancies

Scientific Workshop on Therapy Resistance Mechanisms in Blood Malignancies
Program: Scientific Workshops
Session: Post-Translational Underpinnings of Therapy Response and Resistance to Therapy
Friday, December 8, 2023, 3:29 PM-4:14 PM

Daniel T. Starczynowski, PhD

Cancer Center, University of Cincinnati, Cincinnati, OH

Disclosures: Starczynowski: Sumitomo Pharma Oncology: Research Funding; Captor Therapeutics: Consultancy; Kurome Therapeutics: Consultancy, Current equity holder in private company, Membership on an entity's Board of Directors or advisory committees, Patents & Royalties, Research Funding; Treeline Biosciences: Research Funding; Tolero Therapeutics: Research Funding; Kymera Therapeutics: Consultancy.